Delivery Order SPE2DB20D1100-SPE2DB24FB2Y0

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,568.70 Delivery Order contract is for the supply of Ambien CR 12.5 mg tablets to the agency. The award is not designated under a set-aside program. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,632.06 delivery order is for Ambien CR 6.25 mg tablets, with a period of performance through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,866.22 firm fixed-price delivery order is for the supply of Ambien CR 12.5 mg tablets to support military and federal healthcare programs. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Ambien CR 12.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,279.31, and has an ultimate completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,608.42 firm fixed-price delivery order is for the supply of Ambien CR 12.5 mg tablets. The contract has an ultimate completion date of August 6, 2024. As one of the largest pharmaceutical distributors in the U.S., Amerisourcebergen leverages its extensive supply chain to provide a wide range of medications and medical supplies to the U.S....
This federal contract award is a delivery order (SPE2DB25FVXZ9) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,657.54 firm-fixed-price contract is for the delivery of Ambien CR 6.25 mg tablets. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,423.18 firm-fixed-price delivery order is for the supply of Ambien CR 6.25 mg tablets. This award does not have a set-aside designation. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,087.36 firm-fixed-price delivery order covers the supply of AMBIEN CR 12.5 MG TABLET 100S, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ambien CR 6.25 mg tablets. The Firm Fixed Price contract, valued at $2,586.73, has an ultimate completion date of October 15, 2024. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to provide a wide range of medications and medical supplies to various U.S. government agencies and healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,190.01 firm fixed-price contract is for the supply of Ambien CR 6.25 mg tablets, with a completion date of October 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds Indefinite Delivery Contracts (IDCs) with various federal agencies, including the DLA Troop Support Medical (up to $999,999,999) and the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB2Y0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,747.71 delivery order is for the supply of Ambien CR 6.25 mg tablets to the government, with a period of performance through April 17, 2024.

Amerisourcebergen is a major pharmaceutical distribution company that has been awarded a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

This contract award does not have a set-aside designation, indicating it was issued on a full and open competition basis. Amerisourcebergen leverages its extensive pharmaceutical supply chain network to efficiently fulfill government contracts for critical medical commodities.

Generated 7/16/24, 12:31 PM